This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GlaxoSmithKline Launches New Program To Help Consumers Recycle Empty GSK Respiratory Inhalers

RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2012 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) has introduced a new program to help consumers recycle their empty GSK respiratory inhalers and keep waste out of landfills.  The " Complete the Cycle™ Recycle Program for GSK Respiratory Inhalers is the first of its kind in the pharmaceutical industry and is being offered to community-based retail pharmacies in 31 U.S. markets to make available to their customers.  Currently, inhalers may not be recycled by curb-side recyclers, and therefore likely go to landfills. 

The markets where the program is being offered are Anchorage, AK; Ann Arbor, MI; Atlanta, GA; Austin, TX; Boston, MA; Chicago, IL; Columbus, OH; Dallas/Fort Worth, TX; Denver, CO; Eugene, OR; Grand Rapids, MI; Huntsville, AL; Jacksonville, FL; Kansas City, MO; Lexington, KY; Los Angeles, CA; Louisville, KY; Milwaukee, WI; Minneapolis, MN; New York, NY; Oakland CA; St. Paul, MN; Philadelphia, PA; Portland, OR; Raleigh-Durham, NC; Richmond, VA; Salt Lake City UT; San Francisco, CA; Seattle, WA; St Louis, MO; Syracuse, NY.

Pharmacy enrollment in the program is ongoing and consumers can view a regularly updated list of participating pharmacies on  

"The Complete the Cycle recycling program provides an in-store location for people to drop off empty GSK respiratory inhalers for shipment to a specialized recycler," said Jorge Bartolome, Senior Vice President of GSK's respiratory business area. "GSK piloted the program earlier in five markets and collected nearly 2,700 inhalers. By expanding to 31 U.S. markets, we hope to recycle more than 100,000 empty GSK inhalers."

Program Details

Participating pharmacies will have a Complete the Cycle collection container where customers can deposit empty inhalers as they pick up new prescriptions. Once the boxes are full, pharmacies send the inhalers directly to a specialized recycler where the inhalers will be recycled. The plastics will be used to make new household products, such as plastic hangers and plastic flower pots. The recovered aerosol canister will be sent to a specialist company that will capture remaining gas and recycle the metal components. The inhalers will not be recycled to produce new inhalers.     

The Complete the Cycle   program is being administered for GSK by TerraCycle, the world's leader in the collection and reuse of non-recyclable post-consumer waste. TerraCycle is managing the recruitment of pharmacies and the roll-out of program materials to the participating stores.

GSK Environmental Sustainability

The Complete the Cycle™ recycling program is designed to reduce the environmental impact of GSK inhalers sent to landfills.  It is one of several efforts GSK has in place that focus on environmental sustainability.  GSK's broader sustainability initiatives can be found in the company's 2011 Corporate Responsibility Report

The GSK program aligns with other efforts offered by many pharmacies to collect and recycle items, such as empty drink containers, plastic bags or pill bottles, and was designed in response to the growing U.S. interest in environmental sustainability.  Studies have shown that recycling and sustainability are increasingly important to American consumers.  As an example, a  2011 study from SC Johnson and GfK Roper showed increasing interest in recycling, with 58 percent of American respondents reporting that they recycle on a regular basis. 1

GSK is committed to providing medicines that make a difference while protecting natural resources.  The company aims to minimize environmental impact across the value chain and lifecycle of its products by setting ambitious goals to reduce its carbon footprint, water footprint and waste.  Among the long-term goals, GSK aims to be carbon neutral by 2050, with this ambition extending across the company's operations, suppliers and customers.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.66 -0.09%
FB $118.58 0.85%
GOOG $698.30 0.76%
TSLA $241.82 0.44%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.39 +16.09 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs